ALL
Pharma?in?China
Pharma?Experts
Market News
Products Guide
Brand Story
-
Johnson & Johnson to Acquire Momenta americanpharmaceuticalreview
August 20, 2020Johnson & Johnson has entered into a definitive agreement to acquire Momenta Pharmaceuticals, a company that discovers and develops novel therapies for immune-mediated diseases, in an all cash transaction for approximately $6.5 billion.
Pharma Sources Insight January 2025
